FindTrial
Sign In

MT-6548

DRUG5 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Anemia; Hemodialysis Dependent Chronic Kidney DiseaseAnemia; Non-dialysis Dependent Chronic Kidney DiseaseAnemia; Peritoneal Dialysis Dependent Chronic Kidney DiseaseHealthy

Phase 3

Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
CompletedNCT03329196
Tanabe Pharma CorporationAnemia; Non-dialysis Dependent Chronic Kidney Disease
Start: 2017-10-30End: 2019-08-09Updated: 2026-04-06
Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
CompletedNCT03402386
Tanabe Pharma CorporationAnemia; Peritoneal Dialysis Dependent Chronic Kidney Disease
Start: 2018-01-03End: 2018-12-20Updated: 2026-04-06
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
CompletedNCT03439137
Tanabe Pharma CorporationAnemia; Hemodialysis Dependent Chronic Kidney Disease
Start: 2018-02-14End: 2019-07-16Updated: 2026-04-06
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
CompletedNCT03461146
Tanabe Pharma CorporationAnemia; Hemodialysis Dependent Chronic Kidney Disease
Start: 2018-03-05End: 2018-12-17Updated: 2026-04-06
Effects of Iron Supplements on the Pharmacokinetics of MT-6548
CompletedNCT03645863
Tanabe Pharma CorporationHealthy
Start: 2018-08-27End: 2018-09-30Updated: 2026-04-06

Related Papers

Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studies
Clinical and Experimental Nephrology2024-03-267 citations
In Vitro and Clinical Pharmacokinetic Studies of the Effects of Iron-containing Agents on Vadadustat, an Oral Hypoxia-inducible Factor–Prolyl Hydroxylase Inhibitor
Clinical Therapeutics2021-08-0110 citations
Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study
Nephrology Dialysis Transplantation2021-02-2560 citations